Drug intelligence / Profile preview

Polypodium leucotomos

Development stage
Unknown
Lead developer
Cantabria Labs
Modality
Small Molecules
Administration
Oral, Topical
01

Overview

Polypodium leucotomos is a tropical fern native to Central and South America. Its extract is rich in phenolic compounds such as ferulic acid, caffeic acid, coumaric acid, and vanillic acid. Traditionally used in medicine for its antioxidant properties, it has been investigated primarily for photoprotection and the prevention of skin damage from ultraviolet (UV) radiation. Mechanistically, Polypodium leucotomos acts by inhibiting the generation and release of reactive oxygen species (ROS), preventing UV- and ROS-induced DNA damage through inhibition of AP1 and NF-κB pathways. It also protects natural antioxidant enzyme systems in the skin[6][7]. Clinical studies have explored its use for conditions like actinic keratosis, atopic dermatitis (eczema), melasma, vitiligo, photoprotection against sunburns or rashes from sun exposure[3][4][5]. The extract is available both orally (capsules) and topically (creams). While generally considered safe with minimal side effects when used as directed[1][2], more extensive clinical trials are needed to confirm efficacy across all indications.

Brand names
HeliocareFernblockAnapsos
Other names
Phlebodium aureumPolypodium aureumCalagualaGolden polypodyHares-foot fern
02

Targets

FOS (Activator Protein 1)NF-κB

Beyond the preview

Go deeper on Polypodium leucotomos.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Polypodium leucotomos.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call